p120RasGAP Is a Mediator of Rho Pathway Activation and Tumorigenicity in the DLD1 Colorectal Cancer Cell Line

• Shawna L. Organ,

  Affiliations Princess Margaret Cancer Centre, Toronto, Ontario, Canada, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada

  ⨯
• Josephine Hai,

  Affiliations Princess Margaret Cancer Centre, Toronto, Ontario, Canada, Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada

  ⨯
• Nikolina Radulovich,

  Affiliations Princess Margaret Cancer Centre, Toronto, Ontario, Canada, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada

  ⨯
• Christopher B. Marshall,

  Affiliation Princess Margaret Cancer Centre, Toronto, Ontario, Canada

  ⨯
• Lisa Leung,

  Affiliations Princess Margaret Cancer Centre, Toronto, Ontario, Canada, Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada

  ⨯
• Takehiko Sasazuki,

  Affiliation Department of Pathology, Research Institute, International Medical Center of Japan, Tokyo, Japan

  ⨯
• Senji Shirasawa,

  Affiliation Department of Cell Biology, School of Medicine, Fukuoka University, Fukuoka, Japan

  ⨯
• Chang-Qi Zhu,

  Affiliation Princess Margaret Cancer Centre, Toronto, Ontario, Canada

  ⨯
• Roya Navab,

  Affiliation Princess Margaret Cancer Centre, Toronto, Ontario, Canada

  ⨯
• Mitsuhiko Ikura,

  Affiliations Princess Margaret Cancer Centre, Toronto, Ontario, Canada, Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada

  ⨯
• Ming-Sound Tsao

  * E-mail: ming.tsao@uhn.on.ca

  Affiliations Princess Margaret Cancer Centre, Toronto, Ontario, Canada, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada, Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada

  ⨯